---
title: "Fosun Pharma Gets Regulatory Approval for Myeloma Drug Trial"
description: "Fosun Pharma Gets Regulatory Approval for Myeloma Drug Trial"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/275850233.md"
published_at: "2026-02-13T04:36:45.000Z"
---

# Fosun Pharma Gets Regulatory Approval for Myeloma Drug Trial

### Related Stocks

- [02196.HK - FOSUN PHARMA](https://longbridge.com/en/quote/02196.HK.md)
- [600196.CN - FOSUN PHARMA](https://longbridge.com/en/quote/600196.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Fosun Pharma Unit Gets China Acceptance for Anesthesia Drug Application | Fosun Pharma Unit Gets China Acceptance for Anesthesia Drug Application | [Link](https://longbridge.com/en/news/275893661.md) |
| Shanghai Fosun Pharmaceutical erhält Annahme für Arzneimittelzulassungsantrag | Shanghai Fosun Pharmaceutical (Group) Co. Ltd. announced that a subsidiary's drug approval application has been accepted | [Link](https://longbridge.com/en/news/275434480.md) |
| Fosun Pharma Seeks Approval for New Indication of Cancer Drug | Fosun Pharma Seeks Approval for New Indication of Cancer Drug | [Link](https://longbridge.com/en/news/269679647.md) |
| Oncopeptides launches SEK 200m rights issue to fund Pepaxti rollout and glioblastoma push | Oncopeptides AB has initiated a SEK 200 million rights issue to enhance its balance sheet and support the European rollo | [Link](https://longbridge.com/en/news/276311622.md) |
| Fosun Pharma Gets Greenlight for Tumor Drug Trials | Fosun Pharma Gets Greenlight for Tumor Drug Trials | [Link](https://longbridge.com/en/news/268522001.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.